Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA
Open accessThe DOI matches its Crossref record.
Abstract
Delivery of DNA encoding therapeutic genes in vivo has great potential for treating malignancy as well as genetic diseases. Delivery of placebo DNA without a transgene is used as a control in gene therapy studies. It is tacitly assumed by most investigators that the protein expressed from the transfected DNA has phenotypic consequences, but that the consequences are not from the DNA itself. Here, we demonstrate that transfection of control plasmid DNA (that does not express a gene product) into tumor cell lines induces a dramatic (>10-fold) increase in the expression of the interferon (IFN)-regulated genes IRF7, STAT1, MIG (approved gene symbol CXCL9), MHCI (MICA), and CD11a (ITGAL) in tumor cell lines. Induction of these genes inhibits tumor development and tumor growth in immunocompetent mice that are immunized with apoptotic tumor cells. The antibody depletion study indicates that the underlying mechanism by which transfection of control DNA induces IFN-regulated genes is the induction of a secreting factor(s) such as IFN-beta. Three lines of evidence indicate that DNA transfection-mediated induction of IFN-regulatory genes is independent of TLR9. The three lines of evidence are: (1) TLR9 is not expressed in either SCCVII or 4T1 cell line, (2) activation of TLR9 downstream signaling molecules is not associated with the induction of gene expression, and (3) the secretion factor(s) obtained from the conditioned medium of DNA-transfected SCCVII tumor cells induces the same type of gene expression in the 4T1 tumor cell line, which is refractory to the gene induction by DNA transfection. Our finding indicates that the 4T1 tumor cell line, which is resistant to the DNA transfection-mediated induction of IFN-regulated genes, can be used to determine the real therapeutic gene function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1282 · Cited by 775
DNA damage-induced type I interferon promotes senescence and inhibits stem cell function
Yu, Q., Katlinskaya, Y. V., Carbone, C. J., Zhao, B., Katlinski, K. V., Zheng, H., Guha, M., Li, N., Chen, Q., Yang, T., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.069 · Cited by 260
“Transfection of double-stranded DNA into mammalian cells has been previously shown to stimulate Ifnb expression (Li et al., 2005; Shirota et al., 2006).”
Transient and stable vector transfection: Pitfalls, off-target effects, artifacts
Stepanenko, A. A., & Heng, H. H. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.05.002 · Cited by 109
Rai, T. S., Glass, M., Cole, J. J., Rather, M. I., Marsden, M., Neilson, M., Brock, C., Humphreys, I. R., Everett, R. D., & Adams, P. D. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx771 · Cited by 63
“Transient transfection with plasmid DNA has also been reported to cause secretion of IFN (38).”
Metadata
- Authors
- Li, S., Wilkinson, M., Xia, X., David, M., Xu, L., Purkel-Sutton, A., & Bhardwaj, A.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 11
- Issue
- 1
- Pages
- 112-119
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1963717159
- Cited by
- 35
- References
- 0
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. https://app.cochat.ai/papers/10.1016/j.ymthe.2004.09.008
- The paper
- Li, S., Wilkinson, M., Xia, X., David, M., Xu, L., Purkel-Sutton, A., & Bhardwaj, A. (2005). Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2004.09.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.